<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04730791</url>
  </required_header>
  <id_info>
    <org_study_id>4</org_study_id>
    <nct_id>NCT04730791</nct_id>
  </id_info>
  <brief_title>Validation of the Central Sensitisation Algorithm: Vignette Methods and Utilization to Patients With Chronic Pain</brief_title>
  <official_title>Validation of the Central Sensitisation Algorithm Using an Innovative Application Algo(s)Rithm: A Protocol Based on the Vignette Method.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This protocol will report on the validation process of the Central Sensitisation Algorithm.&#xD;
      The study will include 2 phases. In the first phase, the vignette method will be used while&#xD;
      the second phase will include the use of the algorithm in the evaluation of patients with&#xD;
      chronic pain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For the purposes of the study, in the first phase, clinical vignettes will be created, ie&#xD;
      short hypothetical scenarios of patients with chronic pain. The vignettes will feature&#xD;
      patients with and without Central Sensitisation (CS). Initially, two experts will evaluate&#xD;
      and characterize which vignettes concern patients with CS.&#xD;
&#xD;
      Next, a team of physiotherapists with knowledge of chronic pain and CS will evaluate&#xD;
      vignettes twice: 1) according to their clinical reasoning and 2) according to the algorithm.&#xD;
      There will be an interval of at least 2 weeks between the two measurements. One month later,&#xD;
      the evaluation according to the Algorithm will be repeated. The investigators will design an&#xD;
      Android application &quot;Algo (s) rithm&quot; to enter the questions of the algorithm. In the second&#xD;
      phase, Algo (s)rithm app will use to evaluate patients with chronic pain (including patients&#xD;
      with fibromyalgia) and healthy. The investigators will compare the result with PPT&#xD;
      measurements in the same population.In the present study the inter-rater and test-retest&#xD;
      reliability, criterion validity, construct validity will be examined.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2021</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Algo(s)rithm</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Specialized Algorithm for the categorization of Central Sensitisation. The algorithm is completed by the healthcare professional and includes questions about the patient's clinical picture.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pressure Pain Thresholds PPT</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>The pain pressure threshold (PPT) is used to measure the sensitivity of specific areas. The test quantifies the minimum amount of pressure in a given area, during an increasing pressure of the skin, which is able to change the feeling of pressure in the pain. Measurements will be performed according to protocols used in previous studies (Correa-Rodriquez et al. 2019; Coronado et al. 2018; Wang-Price et al. 2019; Jakorinne et al. 2018; Balaguier et al. 2016)</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Chronic Pain</condition>
  <condition>Central Sensitisation</condition>
  <arm_group>
    <arm_group_label>Chronic Pain Patients</arm_group_label>
    <description>Adult patients 18-65 years, with chronic pain lasting for 3 or more months, with a pain intensity of at least 3 on a 0-10 numerical pain rating scale on most days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with Fibromyalgia</arm_group_label>
    <description>Adult patients 18-65 years. The diagnosis of patients with fibromyalgia will be according to the &quot;criteria for classification of fibromyalgia&quot; by the American college of rheumatology (Wolfe et al 1990).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>Free pain participants</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Algo(s)rithm</intervention_name>
    <description>Specialized Algorithm for the categorization of Central Sensitisation. The algorithm is completed by the healthcare professional and includes questions about the patient's clinical picture.</description>
    <arm_group_label>Chronic Pain Patients</arm_group_label>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_label>Patients with Fibromyalgia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Pressure Pain Threshold</intervention_name>
    <description>The pain pressure threshold (PPT) is used to measure the sensitivity of specific areas. The test quantifies the minimum amount of pressure in a given area, during an increasing skin pressure stimulus, which is capable of altering the feeling of pressure in pain.</description>
    <arm_group_label>Chronic Pain Patients</arm_group_label>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_label>Patients with Fibromyalgia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The measurements will be performed in the research laboratory of Clinical Exercise&#xD;
        Physiology and Rehabilitation (CeprLab) of the University of Thessaly. The sample will&#xD;
        consist of people who will have access to the laboratory regardless of the area of&#xD;
        residence. The participants will be informed through the media (social networking pages,&#xD;
        the official page of the University, the official page of the CeprLab, brochures that will&#xD;
        be sent to physiotherapists and the Panhellenic Association of Physiotherapists).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients 18-65 years&#xD;
&#xD;
          -  with pain &gt; 3months, intensity of at least 3 on a 0-10 numerical pain rating scale on&#xD;
             most days&#xD;
&#xD;
          -  or patients with fibromyalgia (according to the &quot;criteria for classification of&#xD;
             fibromyalgia&quot; by the American college of rheumatology (Wolfe et al 1990)).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who follow a physical therapy program&#xD;
&#xD;
          -  Recent surgery or trauma&#xD;
&#xD;
          -  Pregnant women,&#xD;
&#xD;
          -  Patients with neurological disorders or systemic diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eleni V Kapreli, MSc,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Clinical Exercise Physiology &amp; Rehabilitation Laboratory,University of Thessaly</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eleni V Kapreli, MSc,PhD</last_name>
    <phone>00302231060235</phone>
    <email>ekapreli@uth.gr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paraskevi N Bilika, MSc,PhDcand</last_name>
    <phone>00302231060235</phone>
    <email>pbilika@uth.gr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinical Exercise Physiology and Rehabilitation Laboratory</name>
      <address>
        <city>Lamia</city>
        <state>Sterea Ellada</state>
        <zip>35100</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Smart KM, Blake C, Staines A, Doody C. The Discriminative validity of &quot;nociceptive,&quot; &quot;peripheral neuropathic,&quot; and &quot;central sensitization&quot; as mechanisms-based classifications of musculoskeletal pain. Clin J Pain. 2011 Oct;27(8):655-63. doi: 10.1097/AJP.0b013e318215f16a.</citation>
    <PMID>21471812</PMID>
  </reference>
  <reference>
    <citation>Nijs J, Apeldoorn A, Hallegraeff H, Clark J, Smeets R, Malfliet A, Girbes EL, De Kooning M, Ickmans K. Low back pain: guidelines for the clinical classification of predominant neuropathic, nociceptive, or central sensitization pain. Pain Physician. 2015 May-Jun;18(3):E333-46. Review.</citation>
    <PMID>26000680</PMID>
  </reference>
  <reference>
    <citation>Lluch E, Nijs J, Courtney CA, Rebbeck T, Wylde V, Baert I, Wideman TH, Howells N, Skou ST. Clinical descriptors for the recognition of central sensitization pain in patients with knee osteoarthritis. Disabil Rehabil. 2018 Nov;40(23):2836-2845. doi: 10.1080/09638288.2017.1358770. Epub 2017 Aug 2. Review.</citation>
    <PMID>28768437</PMID>
  </reference>
  <reference>
    <citation>Levesque A, Riant T, Ploteau S, Rigaud J, Labat JJ; Convergences PP Network. Clinical Criteria of Central Sensitization in Chronic Pelvic and Perineal Pain (Convergences PP Criteria): Elaboration of a Clinical Evaluation Tool Based on Formal Expert Consensus. Pain Med. 2018 Oct 1;19(10):2009-2015. doi: 10.1093/pm/pny030.</citation>
    <PMID>29522121</PMID>
  </reference>
  <reference>
    <citation>Nijs J, Leysen L, Adriaenssens N, Aguilar Ferrándiz ME, Devoogdt N, Tassenoy A, Ickmans K, Goubert D, van Wilgen CP, Wijma AJ, Kuppens K, Hoelen W, Hoelen A, Moloney N, Meeus M. Pain following cancer treatment: Guidelines for the clinical classification of predominant neuropathic, nociceptive and central sensitization pain. Acta Oncol. 2016 Jun;55(6):659-63. doi: 10.3109/0284186X.2016.1167958. Epub 2016 May 4.</citation>
    <PMID>27142228</PMID>
  </reference>
  <reference>
    <citation>Nijs J, Polli A, Willaert W, Malfliet A, Huysmans E, Coppieters I. Central sensitisation: another label or useful diagnosis? Drug Ther Bull. 2019 Apr;57(4):60-63. doi: 10.1136/dtb.2018.000035. Epub 2019 Mar 11. Review.</citation>
    <PMID>30858291</PMID>
  </reference>
  <reference>
    <citation>Smart KM, Blake C, Staines A, Thacker M, Doody C. Mechanisms-based classifications of musculoskeletal pain: part 1 of 3: symptoms and signs of central sensitisation in patients with low back (± leg) pain. Man Ther. 2012 Aug;17(4):336-44. doi: 10.1016/j.math.2012.03.013. Epub 2012 Apr 23.</citation>
    <PMID>22534654</PMID>
  </reference>
  <reference>
    <citation>Stacey D, Brière N, Robitaille H, Fraser K, Desroches S, Légaré F. A systematic process for creating and appraising clinical vignettes to illustrate interprofessional shared decision making. J Interprof Care. 2014 Sep;28(5):453-9. doi: 10.3109/13561820.2014.911157. Epub 2014 Apr 28.</citation>
    <PMID>24766619</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 26, 2021</study_first_submitted>
  <study_first_submitted_qc>January 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2021</study_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Algo(s)rithm</keyword>
  <keyword>Vignette Method</keyword>
  <keyword>Central Sensitisation</keyword>
  <keyword>Chronic Pain Categorization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

